Stock comparison
Novartis AG is 40.5x more valuable than Alkermes plc. by market capitalization ($309.21 B vs $7.63 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 40.5x more valuable than Alkermes plc. by market capitalization ($309.21 B vs $7.63 B).
Market value leader
NVS
Novartis AG is 40.5x more valuable than Alkermes plc. by market capitalization ($309.21 B vs $7.63 B).
| Metric | ALKS | NVS |
|---|---|---|
| Market cap | $7.63 B | $309.21 B |
| US-listed rank | #1079 | #38 |
| Revenue (latest FY) | $1.48B | - |
| Net income (latest FY) | $241.70M | - |
| Net margin | 16.4% | - |
| P/E (trailing FY) | 31.6x | - |
| SEC filings | 1,882 | 953 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 40.5x more valuable than Alkermes plc. by market capitalization ($309.21 B vs $7.63 B).
Full pages: Alkermes plc. and Novartis AG, or browse the full rankings.